According to informed sources, Hemab Therapeutics has raised its IPO fundraising target to $301.5 million, expanding its stock offering to 16.75 million shares.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
The company is expected to set its IPO share price at $18 per share, at the top end of the indicated price range. Its Russian investors include Novo Nordisk. (Bloomberg)
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
China’s fertilizer supply is generally guaranteed during the summer harvest season
老虎证券•2026/05/24 00:06
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$76,558.02
+1.61%
Ethereum
ETH
$2,111.74
+2.36%
Tether USDt
USDT
$0.9987
-0.02%
BNB
BNB
$655.6
+0.92%
XRP
XRP
$1.36
+1.93%
USDC
USDC
$0.9997
-0.00%
Solana
SOL
$85.6
+1.68%
TRON
TRX
$0.3621
-0.03%
Dogecoin
DOGE
$0.1028
+1.47%
Hyperliquid
HYPE
$58.8
+8.32%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now